Connection

Kathleen Brady to Psychotropic Drugs

This is a "connection" page, showing publications Kathleen Brady has written about Psychotropic Drugs.
Connection Strength

0.533
  1. Assessing abuse liability in clinical trials. Drug Alcohol Depend. 2003 Jun 05; 70(3 Suppl):S87-95.
    View in: PubMed
    Score: 0.203
  2. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse. 1991; 17(4):389-97.
    View in: PubMed
    Score: 0.086
  3. Weight gain associated with psychotropic drugs. South Med J. 1989 May; 82(5):611-7.
    View in: PubMed
    Score: 0.076
  4. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep. 2007 Oct; 9(5):374-80.
    View in: PubMed
    Score: 0.068
  5. Recognizing and treating dual diagnosis in general health care settings: core competencies and how to achieve them. Subst Abus. 2002 Sep; 23(3 Suppl):143-54.
    View in: PubMed
    Score: 0.048
  6. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol. 2019 Feb; 27(1):45-54.
    View in: PubMed
    Score: 0.037
  7. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005 Dec; 3(1):13-21.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.